IL158927A0 - Method for virus propagation - Google Patents

Method for virus propagation

Info

Publication number
IL158927A0
IL158927A0 IL15892702A IL15892702A IL158927A0 IL 158927 A0 IL158927 A0 IL 158927A0 IL 15892702 A IL15892702 A IL 15892702A IL 15892702 A IL15892702 A IL 15892702A IL 158927 A0 IL158927 A0 IL 158927A0
Authority
IL
Israel
Prior art keywords
virus propagation
virus
propagation
Prior art date
Application number
IL15892702A
Other languages
English (en)
Original Assignee
Bavarian Nordic As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8160630&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL158927(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bavarian Nordic As filed Critical Bavarian Nordic As
Publication of IL158927A0 publication Critical patent/IL158927A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/275—Poxviridae, e.g. avipoxvirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/275—Poxviridae, e.g. avipoxvirus
    • A61K39/285—Vaccinia virus or variola virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/01—DNA viruses
    • C07K14/065—Poxviridae, e.g. avipoxvirus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/01—DNA viruses
    • C07K14/065—Poxviridae, e.g. avipoxvirus
    • C07K14/07—Vaccinia virus; Variola virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24051—Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Toxicology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
IL15892702A 2001-07-18 2002-07-02 Method for virus propagation IL158927A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200101122 2001-07-18
PCT/EP2002/007280 WO2003008533A2 (fr) 2001-07-18 2002-07-02 Methode de multiplication virale

Publications (1)

Publication Number Publication Date
IL158927A0 true IL158927A0 (en) 2004-05-12

Family

ID=8160630

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15892702A IL158927A0 (en) 2001-07-18 2002-07-02 Method for virus propagation
IL158927A IL158927A (en) 2001-07-18 2003-11-18 Method for virus propagation

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL158927A IL158927A (en) 2001-07-18 2003-11-18 Method for virus propagation

Country Status (20)

Country Link
US (1) US6924137B2 (fr)
EP (1) EP1412486B1 (fr)
JP (2) JP4700907B2 (fr)
KR (1) KR100908377B1 (fr)
CN (1) CN100513560C (fr)
AU (1) AU2002314201B2 (fr)
BR (2) BRPI0211276B1 (fr)
CA (1) CA2450206C (fr)
DE (1) DE60223812T2 (fr)
DK (1) DK1412486T3 (fr)
EA (1) EA006628B1 (fr)
HK (1) HK1066245A1 (fr)
HU (1) HUP0400393A3 (fr)
IL (2) IL158927A0 (fr)
MX (1) MXPA04000326A (fr)
NO (1) NO339056B1 (fr)
NZ (1) NZ529914A (fr)
PL (1) PL205926B1 (fr)
UA (1) UA82466C2 (fr)
WO (1) WO2003008533A2 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2256323T5 (es) * 2000-11-23 2016-11-21 Bavarian Nordic A/S Variante del virus Vaccinia Ankara Modificado
US7445924B2 (en) 2000-11-23 2008-11-04 Bavarian Nordic A/S Modified Vaccinia Ankara virus variant and cultivation method
EP1434858B2 (fr) 2002-09-05 2018-12-19 Bavarian Nordic A/S Methode d'amplification d'un poxvirus dans un environnement exempt de serum
US8691502B2 (en) 2008-10-31 2014-04-08 Tremrx, Inc. T-cell vaccination with viral vectors via mechanical epidermal disruption
WO2014009433A1 (fr) 2012-07-10 2014-01-16 Transgene Sa Facteur de ressuscitation de mycobactéries convenant comme adjuvant
KR20150058152A (ko) 2012-07-10 2015-05-28 트랜스진 에스아이 마이코박테리아 항원 백신
WO2015104380A1 (fr) 2014-01-09 2015-07-16 Transgene Sa Fusion d'antigènes mycobactériens hétérooligomères
WO2016131945A1 (fr) 2015-02-20 2016-08-25 Transgene Sa Produit de combinaison modulateur de l'autophagie
FR3042121A1 (fr) 2015-10-08 2017-04-14 Jean-Marc Limacher Composition anti-tumorale
EP3452081A1 (fr) 2016-05-04 2019-03-13 Transgene SA Polythérapie avec un ligand de tlr9 cpg
CA3130928A1 (fr) * 2016-07-12 2018-01-18 EMULATE, Inc. Elimination des bulles dans un dispositif microfluidique
EP3522920A2 (fr) 2016-10-10 2019-08-14 Transgene SA Polythérapie à base d'un produit immunothérapeutique et de modulateurs de mdsc
CN111065406A (zh) 2017-06-21 2020-04-24 特兰斯吉恩股份有限公司 个性化疫苗
EP3842065A1 (fr) 2019-12-23 2021-06-30 Transgene Procédé de conception d'un poxvirus recombinant pour un vaccin thérapeutique
WO2023213764A1 (fr) 2022-05-02 2023-11-09 Transgene Polypeptide de fusion comprenant un anti-pd-l1 sdab et un membre du tnfsf
WO2023213763A1 (fr) 2022-05-02 2023-11-09 Transgene Poxvirus codant pour un agent de liaison comprenant un sdab anti-pd-l1

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2384845A1 (fr) * 1976-08-05 1978-10-20 Anvar Vaccin contre la myxomatose et nouvelle souche virale utilisee
JPS60202827A (ja) * 1984-03-28 1985-10-14 Chibaken 弱毒痘そうワクチン株
CA1341245C (fr) * 1988-01-12 2001-06-05 F. Hoffmann-La Roche Ag Virus recombinant de la vaccine derive du virus modifie ankara
DE4405841C1 (de) * 1994-02-23 1995-01-05 Mayr Anton Prof Dr Med Vet Dr Multipotente Paramunitätsinducer auf der Basis von Kombinationen von Pockenviruskomponenten, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
US5616487A (en) * 1994-09-15 1997-04-01 Aastrom Biosciences, Inc. Stabilized retrovirus compositions
JPH11512609A (ja) * 1995-09-27 1999-11-02 アメリカ合衆国 クローン化されたヌクレオチド配列からの感染性ＲＳウイルス（ｒｅｓｐｉｒａｔｏｒｙ ｓｙｎｃｙｔｉａｌ ｖｉｒｕｓ）の生産
AU3799797A (en) * 1996-07-15 1998-02-09 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences
ES2256323T5 (es) * 2000-11-23 2016-11-21 Bavarian Nordic A/S Variante del virus Vaccinia Ankara Modificado

Also Published As

Publication number Publication date
JP2011078424A (ja) 2011-04-21
EA200400195A1 (ru) 2004-06-24
NO339056B1 (no) 2016-11-07
CA2450206C (fr) 2012-08-21
IL158927A (en) 2009-09-01
JP2004535203A (ja) 2004-11-25
JP4700907B2 (ja) 2011-06-15
EP1412486A2 (fr) 2004-04-28
JP5154632B2 (ja) 2013-02-27
EA006628B1 (ru) 2006-02-24
PL366897A1 (en) 2005-02-07
BR0211276A (pt) 2004-08-03
HUP0400393A3 (en) 2004-10-28
WO2003008533A3 (fr) 2004-01-08
DE60223812D1 (de) 2008-01-10
EP1412486B1 (fr) 2007-11-28
US20040234950A1 (en) 2004-11-25
HK1066245A1 (en) 2005-03-18
KR20040018474A (ko) 2004-03-03
MXPA04000326A (es) 2005-03-07
DK1412486T3 (da) 2008-03-10
PL205926B1 (pl) 2010-06-30
AU2002314201B2 (en) 2006-09-21
BRPI0211276B1 (pt) 2018-12-04
DE60223812T2 (de) 2008-11-13
NZ529914A (en) 2005-03-24
CA2450206A1 (fr) 2003-01-30
KR100908377B1 (ko) 2009-07-20
US6924137B2 (en) 2005-08-02
CN100513560C (zh) 2009-07-15
NO20040158L (no) 2004-01-13
WO2003008533A2 (fr) 2003-01-30
HUP0400393A2 (hu) 2004-07-28
UA82466C2 (uk) 2008-04-25
CN1533433A (zh) 2004-09-29

Similar Documents

Publication Publication Date Title
GB0109993D0 (en) Method
GB0118251D0 (en) Method
IL158927A0 (en) Method for virus propagation
GB0128438D0 (en) Method
GB0109049D0 (en) Method
GB0115243D0 (en) Method
GB0103998D0 (en) Method
GB0116453D0 (en) Method
GB0126531D0 (en) Method
GB0110547D0 (en) Method
GB0101762D0 (en) Method
EP1443415A4 (fr) Procede de calcul parallele
GB0102947D0 (en) Method
GB0116142D0 (en) Method
GB0111987D0 (en) Method
GB0125793D0 (en) Method
GB0119339D0 (en) Method
GB0111442D0 (en) Method for preparing recombinant virus
GB0119269D0 (en) Method
GB0127034D0 (en) Method
GB0109648D0 (en) Method
GB0118160D0 (en) Method
GB0121164D0 (en) Method
GB0126326D0 (en) Method
GB0115389D0 (en) Method